Immunitybio Inc (IBRX)

07:25 AM

Can machine learning forecast ImmunityBio Inc. recovery2025 Risk Factors & Free Low Drawdown Momentum Trade Ideas - newser.com

07:25 AM

07:03 AM

How ImmunityBio Inc. stock reacts to job market dataJuly 2025 Rallies & Daily Price Action Insights - newser.com

07:03 AM

02:12 AM

Tick level data insight on ImmunityBio Inc. volatilityJuly 2025 Recap & Free Fast Gain Swing Trade Alerts - newser.com

02:12 AM

01:51 AM

ImmunityBio Inc. stock trend outlook and recovery pathExit Point & Intraday High Probability Setup Alerts - newser.com

01:51 AM

Oct 13, 2025

Will ImmunityBio Inc. rebound enough to break evenBear Alert & Community Consensus Picks - newser.com

Oct 13, 2025

Oct 13, 2025

Is ImmunityBio Inc. stock a buy on dipsJuly 2025 WrapUp & Community Trade Idea Sharing Platform - newser.com

Oct 13, 2025

Oct 13, 2025

How to recover losses in ImmunityBio Inc. stockJuly 2025 Rallies & Long-Term Investment Growth Plans - newser.com

Oct 13, 2025

Oct 12, 2025

Will ImmunityBio Inc. stock benefit from infrastructure spendingPortfolio Return Report & Low Drawdown Trading Strategies - newser.com

Oct 12, 2025

Oct 11, 2025

Published on: 2025-10-11 12:10:43 - earlytimes.in

Oct 11, 2025

Oct 10, 2025

ImmunityBio, Inc. (IBRX) Reports Strong Q2 Growth, Eyes Lung Cancer and NMIBC Expansion - MSN

Oct 10, 2025

Oct 10, 2025

Why ImmunityBio Inc. (26CA) stock is a strong analyst pick2025 Top Decliners & Daily Profit Focused Stock Screening - newser.com

Oct 10, 2025

Oct 09, 2025

Will EnGene Join The Ranks Of Merck, Ferring, And ImmunityBio In Bladder Cancer Treatment? - RTTNews

Oct 09, 2025

Oct 09, 2025

Will ImmunityBio Inc. stock outperform tech sector in 2025Quarterly Performance Summary & Precise Swing Trade Alerts - newser.com

Oct 09, 2025

Oct 06, 2025

Real time social sentiment graph for ImmunityBio Inc.2025 Pullback Review & Accurate Intraday Trading Signals - newser.com

Oct 06, 2025

Oct 05, 2025

Evaluating ImmunityBio Inc. with trendline analysis2025 Major Catalysts & Growth Oriented Trading Recommendations - newser.com

Oct 05, 2025

Oct 05, 2025

Is ImmunityBio Inc. (26CA) stock prepared for digital transitionJuly 2025 Technicals & Smart Allocation Stock Tips - newser.com

Oct 05, 2025

Oct 05, 2025

ImmunityBio Inc. stock retracement – recovery analysis2025 Investor Takeaways & AI Enhanced Trading Signals - newser.com

Oct 05, 2025

Oct 04, 2025

ANKTIVA Reimbursement Gains and UK Approval Might Change The Case For Investing In ImmunityBio (IBRX) - Sahm

Oct 04, 2025

Oct 03, 2025

ImmunityBio, Inc. (NASDAQ:IBRX) Given Average Recommendation of "Buy" by Brokerages - MarketBeat

Oct 03, 2025

Oct 03, 2025

What Went Wrong With ImmunityBio’s Executives Claims — and How Investors Could Still Win - TradingView

Oct 03, 2025

Oct 03, 2025

ImmunityBio: A Small Bet Is Warranted (NASDAQ:IBRX) - Seeking Alpha

Oct 03, 2025

Oct 03, 2025

NMIBC Market to Experience Notable Growth in Forecast Span - openPR.com

Oct 03, 2025

Oct 03, 2025

Short interest data insights for ImmunityBio Inc.Earnings Growth Report & Technical Pattern Recognition Alerts - newser.com

Oct 03, 2025

Oct 03, 2025

Does ImmunityBio Inc. show high probability of reboundJuly 2025 Pullbacks & Stepwise Trade Signal Implementation - newser.com

Oct 03, 2025

Oct 03, 2025

What MACD and RSI say about ImmunityBio Inc.July 2025 Retail & Weekly High Return Stock Opportunities - newser.com

Oct 03, 2025

Oct 03, 2025

ImmunityBio (IBRX): Revisiting Valuation After ANKTIVA’s Regulatory Wins and New Growth Initiatives - Sahm

Oct 03, 2025

Oct 02, 2025

How high can ImmunityBio Inc. stock go2025 Volume Leaders & AI Powered Trade Plan Recommendations - newser.com

Oct 02, 2025

Oct 02, 2025

Wall Street Bullish on ImmunityBio (IBRX) Since the Announcement of New Findings From QUILT-3.055 Study - MSN

Oct 02, 2025

Oct 02, 2025

ImmunityBio’s (IBRX) ANKTIVA Shows Survival Gains in Lung Cancer Patients - MSN

Oct 02, 2025